Cargando…

Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data

BACKGROUND: Chlormethine gel was approved for treatment of mycosis fungoides, the most common cutaneous T-cell lymphoma, on the basis of results from study 201 and study 202. A post-hoc analysis of study 201 found interesting trends regarding improved efficacy of chlormethine gel vs ointment and not...

Descripción completa

Detalles Bibliográficos
Autores principales: Querfeld, Christiane, Scarisbrick, Julia J., Assaf, Chalid, Kim, Youn H., Guitart, Joan, Quaglino, Pietro, Hodak, Emmilia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334402/
https://www.ncbi.nlm.nih.gov/pubmed/35536441
http://dx.doi.org/10.1007/s40257-022-00687-y
_version_ 1784759097491456000
author Querfeld, Christiane
Scarisbrick, Julia J.
Assaf, Chalid
Kim, Youn H.
Guitart, Joan
Quaglino, Pietro
Hodak, Emmilia
author_facet Querfeld, Christiane
Scarisbrick, Julia J.
Assaf, Chalid
Kim, Youn H.
Guitart, Joan
Quaglino, Pietro
Hodak, Emmilia
author_sort Querfeld, Christiane
collection PubMed
description BACKGROUND: Chlormethine gel was approved for treatment of mycosis fungoides, the most common cutaneous T-cell lymphoma, on the basis of results from study 201 and study 202. A post-hoc analysis of study 201 found interesting trends regarding improved efficacy of chlormethine gel vs ointment and noted a potential association between dermatitis and clinical response. OBJECTIVE: To expand these results by performing a post-hoc analysis of study 202. PATIENTS AND METHODS: Patients received chlormethine gel or ointment during study 201 (12 months) and higher-concentration chlormethine gel during study 202 (7-month extension). Response was assessed using Composite Assessment of Index Lesion Severity (CAILS). Associations between treatment frequency, response, and skin-related adverse events (AEs) were assessed using multivariate time-to-event analyses. Time-to-response and repeated measures analyses were compared between patients who only used chlormethine gel and those who switched from ointment to gel. RESULTS: No associations were seen between treatment frequency and improved skin response (CAILS) or AE occurrence within the 201/202 study populations. However, an association was observed specifically between contact dermatitis and improved CAILS response at the next visit (p < 0.0001). Patients who used chlormethine gel during both studies had a significantly (p < 0.05) shorter time to response and higher overall response rates than patients who initiated treatment with ointment. CONCLUSIONS: This post-hoc analysis shows that patients who initiated treatment using chlormethine gel had faster and higher responses compared with patients who initially used chlormethine ointment for 12 months. The development of contact dermatitis may be a potential prognostic factor for response. TRIAL REGISTRATION NUMBERS AND DATES OF REGISTRATION: Study 201: NCT00168064, September 14, 2002; Study 202: NCT00535470, September 26, 2007. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40257-022-00687-y.
format Online
Article
Text
id pubmed-9334402
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-93344022022-07-30 Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data Querfeld, Christiane Scarisbrick, Julia J. Assaf, Chalid Kim, Youn H. Guitart, Joan Quaglino, Pietro Hodak, Emmilia Am J Clin Dermatol Original Research Article BACKGROUND: Chlormethine gel was approved for treatment of mycosis fungoides, the most common cutaneous T-cell lymphoma, on the basis of results from study 201 and study 202. A post-hoc analysis of study 201 found interesting trends regarding improved efficacy of chlormethine gel vs ointment and noted a potential association between dermatitis and clinical response. OBJECTIVE: To expand these results by performing a post-hoc analysis of study 202. PATIENTS AND METHODS: Patients received chlormethine gel or ointment during study 201 (12 months) and higher-concentration chlormethine gel during study 202 (7-month extension). Response was assessed using Composite Assessment of Index Lesion Severity (CAILS). Associations between treatment frequency, response, and skin-related adverse events (AEs) were assessed using multivariate time-to-event analyses. Time-to-response and repeated measures analyses were compared between patients who only used chlormethine gel and those who switched from ointment to gel. RESULTS: No associations were seen between treatment frequency and improved skin response (CAILS) or AE occurrence within the 201/202 study populations. However, an association was observed specifically between contact dermatitis and improved CAILS response at the next visit (p < 0.0001). Patients who used chlormethine gel during both studies had a significantly (p < 0.05) shorter time to response and higher overall response rates than patients who initiated treatment with ointment. CONCLUSIONS: This post-hoc analysis shows that patients who initiated treatment using chlormethine gel had faster and higher responses compared with patients who initially used chlormethine ointment for 12 months. The development of contact dermatitis may be a potential prognostic factor for response. TRIAL REGISTRATION NUMBERS AND DATES OF REGISTRATION: Study 201: NCT00168064, September 14, 2002; Study 202: NCT00535470, September 26, 2007. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40257-022-00687-y. Springer International Publishing 2022-05-10 2022 /pmc/articles/PMC9334402/ /pubmed/35536441 http://dx.doi.org/10.1007/s40257-022-00687-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research Article
Querfeld, Christiane
Scarisbrick, Julia J.
Assaf, Chalid
Kim, Youn H.
Guitart, Joan
Quaglino, Pietro
Hodak, Emmilia
Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data
title Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data
title_full Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data
title_fullStr Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data
title_full_unstemmed Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data
title_short Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data
title_sort chlormethine gel versus chlormethine ointment for treatment of patients with mycosis fungoides: a post-hoc analysis of clinical trial data
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334402/
https://www.ncbi.nlm.nih.gov/pubmed/35536441
http://dx.doi.org/10.1007/s40257-022-00687-y
work_keys_str_mv AT querfeldchristiane chlormethinegelversuschlormethineointmentfortreatmentofpatientswithmycosisfungoidesaposthocanalysisofclinicaltrialdata
AT scarisbrickjuliaj chlormethinegelversuschlormethineointmentfortreatmentofpatientswithmycosisfungoidesaposthocanalysisofclinicaltrialdata
AT assafchalid chlormethinegelversuschlormethineointmentfortreatmentofpatientswithmycosisfungoidesaposthocanalysisofclinicaltrialdata
AT kimyounh chlormethinegelversuschlormethineointmentfortreatmentofpatientswithmycosisfungoidesaposthocanalysisofclinicaltrialdata
AT guitartjoan chlormethinegelversuschlormethineointmentfortreatmentofpatientswithmycosisfungoidesaposthocanalysisofclinicaltrialdata
AT quaglinopietro chlormethinegelversuschlormethineointmentfortreatmentofpatientswithmycosisfungoidesaposthocanalysisofclinicaltrialdata
AT hodakemmilia chlormethinegelversuschlormethineointmentfortreatmentofpatientswithmycosisfungoidesaposthocanalysisofclinicaltrialdata